Lara Longpre - 10 Nov 2022 Form 4 Insider Report for Mirum Pharmaceuticals, Inc. (MIRM)

Role
Chief Development Officer
Signature
/s/ Jody Howe, Attorney-in-Fact
Issuer symbol
MIRM
Transactions as of
10 Nov 2022
Net transactions value
+$1,398
Form type
4
Filing time
14 Nov 2022, 20:40:20 UTC
Previous filing
12 May 2022
Next filing
02 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MIRM Common Stock Award $1,398 +82 +0.09% $17.05 96,534 10 Nov 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4 is being filed voluntarily to report the acquisition of 82 shares by the Reporting Person on November 10, 2022 pursuant to the Issuer's Employee Stock Purchase Plan.